Table 1.
Baseline characteristics by group
| Variables | Varenicline + nicotine patch N = 170 | Varenicline + placebo N = 171 | P -value |
|---|---|---|---|
| Gender Number (%) | |||
| Male | 95 (55.9%) | 102 (59.6%) | |
| Female | 75 (44.1%) | 69 (40.4%) | 0.55a |
| Age | |||
| Mean (±SD) | 44.1 (±14.8) | 46.2 (±13.1) | 0.38b |
| Cigarettes/day Number (%) | |||
| ≤29 cig/day | 78 (45.9%) | 84 (49.1%) | |
| >29 cig/day | 92 (54.1%) | 87 (50.9%) | 0.60a |
| Previous attempts Number (%) | |||
| None | 33 (19.4%) | 27 (15.8%) | |
| 1 | 73 (42.9%) | 67 (39.2%) | |
| 2 to 3 | 44 (25.9%) | 60 (35.1%) | |
| >3 | 20 (11.8%) | 17 (9.9%) | 0.31a |
| FTND | |||
| Mean (±SD) | 6.1 (±1.6) | 6.8 (±1.8) | 0.9b |
aχ2 squared test; bT-test. FTND, Fagerstrom test for nicotine dependence; SD Standard deviation.